AMPH vs PFE · P/E 12, rev $732.0M vs P/E 20, rev $62.58B
Amphastar P (AMPH) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the AMPH and PFE stock pages for the full models.
Not investment advice.